The detailed information for PTAB case with proceeding number IPR2015-00682 filed by Mylan Pharmaceuticals Inc. against Warner Chilcott Company, LLC et al. on Feb 3, 2015. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2015-00682
Filing Date
Feb 3, 2015
Petitioner
Mylan Pharmaceuticals Inc.
Respondent
Warner Chilcott Company, LLC et al.
Status
Institution Denied
Respondent Application Number
11112290
Respondent Tech Center
1600
Respondent Patent Number
7704984
Institution Decision Date
Aug 20, 2015
Termination Date
Aug 20, 2015

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Order Termination of the Proceeding

Aug 20, 2015PAPERBOARD

Joint Motion to Terminate Pursuant to 35 USC 317 and 37 CFR 42.74

Aug 19, 2015PAPERPATENT OWNER

Joint Request to File Settlement Agreement as Business Confidential Information

Aug 19, 2015PAPERPATENT OWNER

Patent Owner's Updated Exhibit List

Aug 19, 2015PAPERPATENT OWNER

Ex. 2033 - Business Confidential Settlement Agreement

Aug 19, 2015EXHIBITPATENT OWNER

Patent Owner Preliminary Response

May 21, 2015PAPERPATENT OWNER

Ex. 2001 District Court Opinion

May 21, 2015EXHIBITPATENT OWNER

Ex. 2002 Federal Circuit Opinion

May 21, 2015EXHIBITPATENT OWNER

Ex. 2003 Trial Transcripts Excerpts

May 21, 2015EXHIBITPATENT OWNER

Ex. 2004 Speroff 4th ed.

May 21, 2015EXHIBITPATENT OWNER

Ex. 2005 Speroff 3d ed. - part 1

May 21, 2015EXHIBITPATENT OWNER

Ex. 2005 Speroff 3d ed. - part 2

May 21, 2015EXHIBITPATENT OWNER

Ex. 2005 Speroff 3d ed. - part 3

May 21, 2015EXHIBITPATENT OWNER

Ex. 2005 Speroff 3d ed. - part 4

May 21, 2015EXHIBITPATENT OWNER

Ex. 2006 Lo Loestrin Fe Prescribing Information

May 21, 2015EXHIBITPATENT OWNER

Ex. 2007 van Heusden

May 21, 2015EXHIBITPATENT OWNER

Ex. 2008 Teichmann

May 21, 2015EXHIBITPATENT OWNER

Ex. 2009 U.S. Patent 5,980,940

May 21, 2015EXHIBITPATENT OWNER

Ex. 2010 Kaunitz

May 21, 2015EXHIBITPATENT OWNER

Ex. 2011 Darney

May 21, 2015EXHIBITPATENT OWNER

Ex. 2012 Thorneycroft

May 21, 2015EXHIBITPATENT OWNER

Ex. 2013 Akerlund

May 21, 2015EXHIBITPATENT OWNER

Ex. 2014 Marut

May 21, 2015EXHIBITPATENT OWNER

Ex. 2015 U.S. Patent No. 4,292,315

May 21, 2015EXHIBITPATENT OWNER

Ex. 2016 Serfaty

May 21, 2015EXHIBITPATENT OWNER

Ex. 2017 Lammers

May 21, 2015EXHIBITPATENT OWNER

Ex. 2018 Task Force on Oral Contraceptives

May 21, 2015EXHIBITPATENT OWNER

Ex. 2019 Bounds

May 21, 2015EXHIBITPATENT OWNER

Ex. 2020 Szarewski

May 21, 2015EXHIBITPATENT OWNER

Ex. 2021 U.S. Patent 4,921,843

May 21, 2015EXHIBITPATENT OWNER

Ex. 2022 Deposition Transcript Excerpts - Kurt Barnhart, M.D.

May 21, 2015EXHIBITPATENT OWNER

Ex. 2023 Miscellaneous Trial Exhibits

May 21, 2015EXHIBITPATENT OWNER

Ex. 2024 Sullivan

May 21, 2015EXHIBITPATENT OWNER

Ex. 2025 Gestodene Study Group 324

May 21, 2015EXHIBITPATENT OWNER

Ex. 2026 Endrikat

May 21, 2015EXHIBITPATENT OWNER

Ex. 2027 Szarewski 3d ed.

May 21, 2015EXHIBITPATENT OWNER

Ex. 2028 Complaint

May 21, 2015EXHIBITPATENT OWNER

Ex. 2029 Answer and Counterclaims

May 21, 2015EXHIBITPATENT OWNER

Ex. 2030 Scheduling Order

May 21, 2015EXHIBITPATENT OWNER

Ex. 2031 Thomas 2001

May 21, 2015EXHIBITPATENT OWNER

Ex. 2032 Thomas 1993

May 21, 2015EXHIBITPATENT OWNER

Notice of filing Date Accorded to Petition

Feb 24, 2015PAPERBOARD

Power of Attorney

Feb 20, 2015PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Related Matters

Feb 20, 2015PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Petition for Inter Partes Review of U.S. Patent No. 7,704,984

Feb 3, 2015PAPERPETITIONER

Power of Attorney

Feb 3, 2015PAPERPETITIONER

U.S. Patent No. 7,704,984

Feb 3, 2015EXHIBITPETITIONER

File Wrapper - U.S. Patent No. 7,704,984

Feb 3, 2015EXHIBITPETITIONER

PCT Application No. PCT/US97/07074

Feb 3, 2015EXHIBITPETITIONER

U.S. Patent No. 6,667,050

Feb 3, 2015EXHIBITPETITIONER

U.S. Patent No. 5,552,394

Feb 3, 2015EXHIBITPETITIONER

Hormone Withdrawl Symptoms in Oral Contraceptive Users

Feb 3, 2015EXHIBITPETITIONER

U.S. Patent Publication No. 2003/0139381

Feb 3, 2015EXHIBITPETITIONER

U.S. Patent No. 5,756,490

Feb 3, 2015EXHIBITPETITIONER

U.S. Patent No. 5,980,940

Feb 3, 2015EXHIBITPETITIONER

Physicians' Desk Reference 56th Edition 2002

Feb 3, 2015EXHIBITPETITIONER

Drug Details for Loestrin 21 1/20

Feb 3, 2015EXHIBITPETITIONER

Drug Details for loestrin Fe 1/20

Feb 3, 2015EXHIBITPETITIONER

Clinical Gynecologic Endocrinology and Infertility

Feb 3, 2015EXHIBITPETITIONER

Effect of low-dose oral contraceptive on gonadotropins, androgens, a sex hormone binding globulin in nonhirsute women

Feb 3, 2015EXHIBITPETITIONER

Changes in androgens during treatment with four low-dose contraceptives

Feb 3, 2015EXHIBITPETITIONER

The forgotten pill - and the paramount importance of the pill-free week

Feb 3, 2015EXHIBITPETITIONER

Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception

Feb 3, 2015EXHIBITPETITIONER

Progestogen-only pills and bleeding disturbances

Feb 3, 2015EXHIBITPETITIONER

Combined hormonal contraceptive methods

Feb 3, 2015EXHIBITPETITIONER

FDA Guidance for Industry - Labeling for Combined Oral Contraceptives

Feb 3, 2015EXHIBITPETITIONER

European Patent No. EP 206 607

Feb 3, 2015EXHIBITPETITIONER

John Rock's error what the co-inventor of the pill didn't know

Feb 3, 2015EXHIBITPETITIONER

Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combined oral contraceptive

Feb 3, 2015EXHIBITPETITIONER

Menstrual impact of contraception

Feb 3, 2015EXHIBITPETITIONER

Biologic effects of various doses of ethinyl estradiol in postmenopausal women

Feb 3, 2015EXHIBITPETITIONER

Noncontraceptive effects of oral contraceptives

Feb 3, 2015EXHIBITPETITIONER

Contraception in Reproductive Endocrinology

Feb 3, 2015EXHIBITPETITIONER

Declaration of Michael A. Thomas, M.D.

Feb 3, 2015EXHIBITPETITIONER